Obesity Clinical Trial
— NudgeOfficial title:
A Micro-randomized Trial of JITAI Messaging to Improve Adherence to Multiple Weight Loss Behaviors in Young Adults
Verified date | June 2024 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this micro-randomized trial is to evaluate the effects of 7 types of intervention messages targeting specific behavior change techniques (i.e., BCT messages) delivered in "just-in-time" (JIT) moments on daily achievement of weight-related behavioral goals among n=201 young adults with overweight and obesity, participating in a digital, mobile comprehensive lifestyle intervention. "Just-in-time adaptive interventions" (JITAIs) are an alternative to the "one size fits all" approach of mobile intervention development that can provide tailored, real-time messaging and support for young adults.
Status | Active, not recruiting |
Enrollment | 201 |
Est. completion date | March 2025 |
Est. primary completion date | January 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility | Inclusion Criteria: - Body mass index (BMI) of 25 - 45 kg/m^2 at baseline - English-speaking, reading, and writing - Own a smartphone with a data and text messaging plan Exclusion Criteria: - Type 1 diabetes or currently receiving medical treatment for Type 2 diabetes - Report a heart condition, chest pain during periods of activity or rest, or loss of consciousness on the Physical Activity Readiness Questionnaire (PAR-Q; items 1-4). - Other health problems which may influence the ability to walk for physical activity or be associated with unintentional weight change, including cancer treatment within the past 5 years or tuberculosis - Lost 10 lbs. or more of body weight (and kept it off) in the last 3 months - Past diagnosis of or receiving treatment for a clinically diagnosed eating disorder (anorexia nervosa or bulimia nervosa) - Current symptoms of alcohol or substance dependence - Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 6 months - Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months - Hospitalization for depression or other psychiatric disorder within the past 12 months - History of psychotic disorder or bipolar disorder - Currently participating in a weight loss, nutrition, or physical activity study or program or other study that would interfere with this study - Currently using prescription medications with known effects on appetite or weight (e.g., oral steroids, weight loss medications), with the exception of individuals on a stable dose of Selective Serotonin Reuptake Inhibitors (SSRIs) for 3 months) - Previous surgical procedure for weight loss or planned weight loss surgery in the next year - Another member of the household is a participant or staff member on this trial - Reason to suspect that the participant would not adhere to the study intervention - Reside outside of the United States |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina at Chapel Hill | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Met daily weighing goal | Wireless scales will be used to collect daily weight measurements, which are transmitted directly to the study app servers in real time. Participants are instructed to weigh each day. On the day of randomization, a dichotomous outcome of whether a participant weighed or did not weigh is assessed. | Daily throughout the study, a total of up to 24 weeks | |
Primary | Met daily active minutes goal | Activity trackers will be used to collect daily active minutes, which are minutes of moderate-to-vigorous intensity physical activity accumulated in bouts of at least 10 minutes. On the day of randomization, a dichotomous outcome of whether a participant met or exceeded their daily active minutes goal or not is assessed. Days with no tracker wear are counted as not meeting the goal. | Daily throughout the study, a total of up to 24 weeks | |
Primary | At or under daily red foods limit | Participants will record red foods in the study app; data sync with study servers in real time from the participants' app. On the day of randomization, a dichotomous outcome of whether a participant stayed at or under their red foods limit or not is assessed. Days without complete red food tracking are counted as not meeting the red foods limit. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Weight change | Absolute weight change (kg) from baseline to 6 months. Weight will be objectively measured on a digital scale in the participant's home. | Baseline, 6 months | |
Secondary | Percent weight change | Change in weight (%) from baseline to 6 months. Weight will be objectively measured on a digital scale in the participant's home. Percent weight change at 6 months is calculated as ((weight (kg) at 6 months - weight (kg) at baseline)/(weight (kg) at baseline))*100 | Baseline, 6 months | |
Secondary | Proportion of days met daily weighing goal | Calculation of the proportion of study days weighed. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Proportion of daily active minutes goal met | Calculation of the proportion of daily active minutes goal met using activity tracker data. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Proportion of daily red foods limit | Calculation of the proportion of the daily red foods limit recorded in the study app. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Number of active minutes | Total number of active minutes on the day of message randomization (at the participant-day level) across the 6 month study. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Number of red foods | Total number of red foods on the day of message randomization (at the participant-day level) across the 6 month study. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Met daily weighing goal tomorrow | Wireless scales will be used to collect daily weight measurements, which are transmitted directly to the study app servers in real time. Participants are instructed to weigh each day. On the day after randomization, a dichotomous outcome of whether a participant weighed or did not weigh is assessed. | Daily throughout the study, a total of up to 24 weeks | |
Secondary | Met daily active minutes goal tomorrow | Activity trackers will be used to collect daily active minutes, which are minutes of moderate-to-vigorous intensity physical activity accumulated in bouts of at least 10 minutes. On the day after randomization, a dichotomous outcome of whether a participant met or exceeded their daily active minutes goal or not is assessed. (Days with no tracker wear are counted as not meeting the goal). | Daily throughout the study, a total of up to 24 weeks | |
Secondary | At or under daily red foods limit tomorrow | Participants will record red foods in the study app; data sync with study servers in real time from the participants' app. On the day after randomization, a dichotomous outcome of whether a participant stayed at or under their red foods limit or not is assessed. Days without complete red food tracking are counted as not meeting the red foods limit. | Daily throughout the study, a total of up to 24 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |